Immunovative Therapies Ltd - Company Review
Immunovative Therapies Ltd - Company ReviewSummary
Immunovative Therapies Ltd (ITL) is a biopharmaceutical company that offers therapies. The company research and develops immunotherapy drug products for treatment of cancer and infectious disease. It provides therapeutic vaccine products such as allovax, allostim, and cryovax. ITL offers products and services in the therapeutic areas such as breast cancer, hematological malignancy, prostate cancer, glioblastoma multiforme brain tumor, colorectal cancer with liver metastases, kidney cancer and non-small cell lung cancer. The company’s allostim comprises various immunomodulatory and immunostimulatory properties. It operates through other pharmaceutical and clinical trial organizations for the development of products and technologies. ITL is headquartered in Jerusalem, Israel.
This comprehensive company report of Immunovative Therapies Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.